Bvf INC/il

10% owner at ESSA Pharma Inc.; Other at Third Harmonic Bio, Inc.; Other at POINT Biopharma Global Inc., and 10 more

Sold, on record
$335M
Dollars the filings state
Form 4 sales
18
Latest Aug 5, 2025
Form 144 notices
0
Proposed sales
Companies
13
Filed as an executive or holder

Companies

Sales by reason

0
Routine
9
Plan not stated
1
No plan
8
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Aug 5, 2025No plan

    ESSA Pharma Inc.

    Sold under 0.1% of their holdings

    $293156 shares at $1.88

    Filed Aug 7, 2025Form 4

  2. Oct 29, 2024Unusual

    Third Harmonic Bio, Inc.

    Sold 85% of their holdings

    $14.3M1M shares at $14.30

    Filed Oct 31, 2024Form 4

  3. Dec 18, 2023Unusual

    POINT Biopharma Global Inc.

    Sold 100% of their holdings

    $214M17.2M shares at $12.45

    Filed Dec 20, 2023Form 4

  4. Mar 31, 2021Unusual

    XOMA LTD /DE/

    Sold 89.6% of their holdings

    $25M651,700 shares at $38.36

    Filed Apr 2, 2021Form 4

  5. Feb 11, 2021Unusual

    INFINITY PHARMACEUTICALS, INC.

    Sold 80.9% of their holdings

    $12.1M2.3M shares at $5.37

    Filed Feb 16, 2021Form 4

  6. Nov 4, 2015Plan not stated

    ChemoCentryx, Inc.

    Sold 13.1% of their holdings

    $2.5M360,000 shares at $7.00

    Filed Nov 5, 2015Form 4

  7. Jun 10, 2015Unusual

    ChemoCentryx, Inc.

    Sold 25.5% of their holdings

    $8.6M955,700 shares at $9.00

    Filed Jun 11, 2015Form 4

  8. Nov 27, 2013Plan not stated

    LGND

    Sold 20.8% of their holdings

    $30.2M527,505 shares at $57.27

    Filed Nov 29, 2013Form 4

  9. Nov 19, 2013Unusual

    RIGL

    Sold 42.8% of their holdings

    $1.3M484,622 shares at $2.64

    Filed Nov 20, 2013Form 4

  10. Apr 20, 2010Plan not stated

    SUPERGEN INC

    Sold 3% of their holdings

    $604k170,000 shares at $3.56

    Filed Apr 21, 2010Form 4

10 of 18

Every transaction

Every transaction on a Form 4 or Form 5 by Bvf INC/il
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Oct 9, 2025Oct 14, 2025ESSA Pharma Inc.10% ownerTendered11.5M0SEC
Aug 5, 2025Aug 7, 2025ESSA Pharma Inc.10% ownerExercised or settledPre-funded Warrants2.9M0SEC
Aug 5, 2025Aug 7, 2025ESSA Pharma Inc.10% ownerExercised options2.9M560,808SEC
Aug 5, 2025Aug 7, 2025ESSA Pharma Inc.10% ownerSold156$1.88$293560,797SEC
Jun 11, 2025Jun 13, 2025OLMADirectorAwardedStock Option (Right to buy)24,15024,150SEC
Jun 5, 2025Jun 9, 2025MLTXDirector, 10% ownerAwardedOption to Buy6,6826,682SEC
Dec 4, 2024Dec 4, 2024OLMADirectorReturned to the company3.4M370,710SEC
Dec 4, 2024Dec 4, 2024OLMADirectorAwardedPre-Funded Warrant5.8M$3.84$22.4M313,548SEC
Oct 29, 2024Oct 31, 2024Third Harmonic Bio, Inc.OtherSold1M$14.30$14.3M176,692SEC
May 9, 2024May 13, 2024ELDN10% ownerBoughtPre-funded Warrants to Purchase Common Stock5.9M232,068SEC
May 9, 2024May 13, 2024ELDN10% ownerBought1.9M220,460SEC
Dec 18, 2023Dec 20, 2023POINT Biopharma Global Inc.OtherSold17.2M$12.45$214M0SEC
Jun 15, 2022Jun 17, 2022KYMRDirectorAwardedStock Option (Right to Buy)12,00012,000SEC
May 13, 2022May 16, 2022CGEM10% ownerBought1.1M$9.07$10.1M319,415SEC
May 6, 2022May 9, 2022KYMRDirectorBought250,000$19.46$4.9M216,735SEC
Jan 31, 2022Jan 31, 2022KYMROtherBought130,309$38.96$5.1M1.4MSEC
Jan 7, 2022Jan 10, 2022Rain Oncology Inc.10% ownerBought557,728$12.00$6.7M185,388SEC
Mar 31, 2021Apr 2, 2021XOMA LTD /DE/10% ownerSold651,700$38.36$25M149,975SEC
Feb 11, 2021Feb 16, 2021INFINITY PHARMACEUTICALS, INC.10% ownerSold2.3M$5.37$12.1M534,847SEC
Nov 4, 2020Nov 6, 2020CBIO10% ownerBought1.3M$2.60$3.3M630,453SEC
Oct 30, 2020Nov 3, 2020CBIO10% ownerBought932,612$2.75$2.6M544,363SEC
Sep 22, 2020Sep 24, 2020FIVE PRIME THERAPEUTICS INC10% ownerBought32$3.80$122541,116SEC
Sep 10, 2020Sep 14, 2020Merus N.V.10% ownerBought189,651$11.10$2.1M372,526SEC
May 14, 2020May 18, 2020FIVE PRIME THERAPEUTICS INC10% ownerBought293,587$4.10$1.2M541,084SEC
Oct 25, 2019Oct 25, 2019FIVE PRIME THERAPEUTICS INC10% ownerBought169,370$3.74$634k346,627SEC
Dec 13, 2018Dec 13, 2018XOMA LTD /DE/10% ownerBought36,463$14.46$527k693,541SEC
Nov 28, 2018Nov 30, 2018INFINITY PHARMACEUTICALS, INC.10% ownerBought100,000$1.30$130k6.5MSEC
Nov 21, 2018Nov 21, 2018INFINITY PHARMACEUTICALS, INC.10% ownerBought1.5M$1.37$2M1.3MSEC
May 11, 2017May 11, 2017ALPINE IMMUNE SCIENCES, INC.10% ownerBought109,034$2.33$254k178,428SEC
Dec 20, 2016Dec 20, 2016INFINITY PHARMACEUTICALS, INC.10% ownerBought654,921$1.31$856k621,547SEC
Nov 5, 2015Nov 5, 2015ChemoCentryx, Inc.OtherOther2.4M0SEC
Nov 4, 2015Nov 5, 2015ChemoCentryx, Inc.OtherSold360,000$7.00$2.5M2.4MSEC
Jun 10, 2015Jun 11, 2015ChemoCentryx, Inc.10% ownerSold955,700$9.00$8.6M2.8MSEC
Dec 17, 2014Dec 17, 2014Oncothyreon Inc.10% ownerBought378,444$1.82$688k3.3MSEC
Nov 27, 2013Nov 29, 2013LGND10% ownerSold527,505$57.27$30.2M2MSEC
Nov 19, 2013Nov 20, 2013RIGL10% ownerSold484,622$2.64$1.3M646,559SEC
Nov 1, 2013Nov 1, 2013ChemoCentryx, Inc.10% ownerBought336,225$4.99$1.7M1.1MSEC
Oct 3, 2013Oct 7, 2013ChemoCentryx, Inc.10% ownerBought109,425$5.49$601k524,011SEC
Dec 14, 2012Dec 18, 2012LGND10% ownerBought5,386$18.63$100k2.1MSEC
Oct 21, 2011Oct 25, 2011LGND10% ownerBought4,600$13.93$64k1.7MSEC
Jul 26, 2011Jul 28, 2011CAPS10% ownerBought18,400$0.25$5k3.7MSEC
Jul 11, 2011Jul 13, 2011CAPS10% ownerBought9,000$0.25$2k3.2MSEC
Jun 30, 2011Jul 5, 2011CAPS10% ownerBought4,700$0.25$1k3.2MSEC
Apr 20, 2010Apr 21, 2010SUPERGEN INC10% ownerSold170,000$3.56$604k5.6MSEC
Apr 5, 2010Apr 7, 2010ARQULE INC10% ownerSold603,000$6.13$3.7M4.2MSEC
Feb 9, 2010Feb 9, 2010FACET BIOTECH CORP10% ownerBought39,200$15.48$607k3.9MSEC
Jan 29, 2010Jan 29, 2010FACET BIOTECH CORP10% ownerBought271,600$15.69$4.3M3.7MSEC
Sep 21, 2009Sep 21, 2009ADOLOR CORP10% ownerSold402,000$1.67$672k4.5MSEC
Sep 10, 2009Sep 11, 2009DYNAVAX TECHNOLOGIES CORP10% ownerSold1.2M$2.76$3.3M4.3MSEC
Aug 24, 2009Aug 26, 2009LGND10% ownerSold4.6M$2.57$11.7M10.6MSEC
Page 1

Sales and notices (18)

Form 144 notices and Form 4 sales by Bvf INC/il
Source
Aug 5, 2025Aug 7, 2025ESSA Pharma Inc.10% ownerForm 4 sale156$2930.0%No planSEC
Oct 29, 2024Oct 31, 2024Third Harmonic Bio, Inc.OtherForm 4 sale1M$14.3M85.0%UnusualSEC
Dec 18, 2023Dec 20, 2023POINT Biopharma Global Inc.OtherForm 4 sale17.2M$214M100.0%UnusualSEC
Mar 31, 2021Apr 2, 2021XOMA LTD /DE/10% ownerForm 4 sale651,700$25M89.6%UnusualSEC
Feb 11, 2021Feb 16, 2021INFINITY PHARMACEUTICALS, INC.10% ownerForm 4 sale2.3M$12.1M80.9%UnusualSEC
Nov 4, 2015Nov 5, 2015ChemoCentryx, Inc.OtherForm 4 sale360,000$2.5M13.1%Plan not statedSEC
Jun 10, 2015Jun 11, 2015ChemoCentryx, Inc.10% ownerForm 4 sale955,700$8.6M25.5%UnusualSEC
Nov 27, 2013Nov 29, 2013LGND10% ownerForm 4 sale527,505$30.2M20.8%Plan not statedSEC
Nov 19, 2013Nov 20, 2013RIGL10% ownerForm 4 sale484,622$1.3M42.8%UnusualSEC
Apr 20, 2010Apr 21, 2010SUPERGEN INC10% ownerForm 4 sale170,000$604k3.0%Plan not statedSEC
Apr 5, 2010Apr 7, 2010ARQULE INC10% ownerForm 4 sale603,000$3.7M12.5%Plan not statedSEC
Sep 21, 2009Sep 21, 2009ADOLOR CORP10% ownerForm 4 sale402,000$672k8.2%Plan not statedSEC
Sep 10, 2009Sep 11, 2009DYNAVAX TECHNOLOGIES CORP10% ownerForm 4 sale1.2M$3.3M22.1%Plan not statedSEC
Aug 24, 2009Aug 26, 2009LGND10% ownerForm 4 sale4.6M$11.7M30.0%UnusualSEC
Jul 14, 2009Jul 15, 2009ADOLOR CORP10% ownerForm 4 sale725,500$1.2M11.7%Plan not statedSEC
Jul 1, 2009Jul 6, 2009LGND10% ownerForm 4 sale142,700$424k0.9%Plan not statedSEC
Jun 29, 2009Jun 29, 2009LGND10% ownerForm 4 sale829,265$2.4M5.1%Plan not statedSEC
Apr 27, 2009Apr 29, 2009CRIS10% ownerForm 4 sale3M$3.4M33.3%UnusualSEC